Brief: Pierrel Unit Receives Go-Ahead To Commercialise Orabloc® In Bangladesh
March 1 (Reuters) - Pierrel SpA PRL.MI :
* UNIT PIERREL PHARMA OBTAINS AUTHORISATION TO COMMERCIALISE
ORABLOC® IN BANGLADESH
Source text for Eikon: ID:nBIA1F5r72
Further company coverage: PRL.MI
(Gdansk newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Pierrel SpA
See all newsBrief: Pierrel To Stop Trading On Euronext Milan As Of Jan. 24
Brief: PRL Crosses 95% Threshold In Pierrel Share Capital Through Takeover Bid, To Start Delisting
Brief: Prl Extended To 20 Dec. Acceptance Period Of Takeover Bid On Pierrel
Italy - Factors to watch on Dec. 15
Italy - Factors to watch on Nov. 27